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Abstract
Sulforaphane (SFN) is a naturally-occurring isothiocyanate best known for its role as an indirect antioxidant.
Notwithstanding, in different cancer cell lines, SFN may promote the accumulation of reactive oxygen species (ROS) and
cause cell death e.g. by apoptosis. Osteosarcoma often becomes chemoresistant, and new molecular targets to prevent
drug resistance are needed. Here, we aimed to determine the effect of SFN on ROS levels and to identify key biomarkers
leading to ROS unbalance and apoptosis in the p53-null MG-63 osteosarcoma cell line. MG-63 cells were exposed to SFN for
up to 48 h. At 10 mM concentration or higher, SFN decreased cell viability, increased the%early apoptotic cells and increased
caspase 3 activity. At these higher doses, SFN increased ROS levels, which correlated with apoptotic endpoints and cell
viability decline. In exposed cells, gene expression analysis revealed only partial induction of phase-2 detoxification genes.
More importantly, SFN inhibited ROS-scavenging enzymes and impaired glutathione recycling, as evidenced by inhibition of
glutathione reductase (GR) activity and combined inhibition of glutathione peroxidase (GPx) gene expression and enzyme
activity. In conclusion, SFN induced oxidative stress and apoptosis via a p53-independent mechanism. GPx expression and
activity were found associated with ROS accumulation in MG-63 cells and are potential biomarkers for the efficacy of ROS-
inducing agents e.g. as co-adjuvant drugs in osteosarcoma.
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Introduction
Osteosarcoma is the most frequent primary solid malignancy of
the bone and shows higher incidence in children, adolescents and
young adults [1], [2]. The overall survival of nonmetastatic
osteosarcoma patients has improved substantially with the
introduction of adjuvant and neoadjuvant chemotherapy regi-
mens. However, to improve the prognosis of patients with
detectable metastatic, recurrent or nonresectable osteosarcoma,
more selective and potent drugs need to be developed [3], [4], [5],
[6].
Epidemiological data continue to show that dietary intake of
cruciferous vegetables (Brassicaceae) may protect against carcino-
genesis, reviewed in [7], [8]. Sulforaphane (SFN), a natural
isothiocyanate found in Brassicaceae, has been shown to possess
anticancer and anti-inflammatory activities in many cancer cell
lines [9], [10], [11], [12]. SFN is best known for its role as an
indirect antioxidant, as it induces several phase 2 detoxification
enzymes [13], [14] and inhibits procarcinogenic phase 1 enzymes
[15]. This isothiocyanate can decrease cell proliferation by causing
cell cycle arrest and inducing apoptosis [12], [16], [17]. In tumour
cells, SFN may induce apoptosis by death receptor 5, activator
protein 1, mitogen-activated protein kinases or mitochondrial
dysfunction, and additionally SFN may suppress concurring
prosurvival pathways, e.g. via active inhibition of the nuclear
factor-kappa B activation [17], [18], [19]. Other potential
mechanism of SFN action via SFN-conjugates is histone
deacetylase inhibition, which was shown to increase histone
acetylation at the promoters of p21 and Bax, and was associated
with cell cycle arrest and apoptosis [20], [21]. In osteosarcoma,
SFN has been found to induce apoptosis via activation of the
death-receptor pathway [17]. Despite its role as an indirect
antioxidant and inducer of Antioxidant Response Element (ARE)
genes, there is evidence that exposure to SFN results in a transient
reactive oxygen species (ROS) burst, of which the duration and
magnitude are both dependent on the SFN concentration and
exposure period. In different cancer cell lines it has been reported
that activation of apoptosis by SFN is highly dependent on ROS
generation, as the apoptotic effect could be counteracted with
ectopic catalase (Cat) expression [22], [23], [24], [25], [26].
Recent studies have shown that cells with low mitochondrial
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respiratory chain activity are mostly protected from SFN-induced
DNA breakage, G2/M phase arrest, disruption of mitochondrial
membrane potential and apoptosis [23], [26], [27]. These
observations reinforced the notion that the mitochondrial respi-
ratory chain is the main site for SFN-induced ROS production
and subsequent ROS-induced cellular alterations. Overall, the
development of drugs targeting ROS-sensitive cancer cells shows
much potential to chemotherapy [28], [29].
In osteosarcoma, wild-type p53 function is frequently altered or
entirely absent [2]. Several anticancer agents, e.g. etoposide or 5-
fluorouracil, however, predominantly induce apoptosis via a p53-
dependent mechanism [30] and this action may render these
agents less effective in p53-deficient osteosarcoma therapy.
The aims of this work are to test SFN efficacy in inducing ROS
in a p53-null osteosarcoma cell line, and to evaluate the most
sensitive biomarkers to assess oxidative stress within this model.
For this, the p53-null model cell line MG-63was exposed to SFN
and several parameters related to oxidative state were assessed and
correlated with cytotoxicity and apoptosis induced by SFN
treatment.
Materials and Methods
Cell Culture and Exposure Treatment
All cell culture reagents were purchased from Life Technologies
(Carlsbad, CA-USA), unless otherwise stated. Human osteosarco-
ma MG-63 cell line (ATCC, Manassas, VA-USA) was cultured in
a-Minimum Essential Medium supplemented with 10% foetal
bovine serum, 2.5 mg/ml fungizone, and 100 U/ml penicillin-
100 mg/ml streptomycin at 37uC in a humidified atmosphere
containing 5% CO2. When ,80% cell confluence was reached,
cells were trypsinised with Trypsin-EDTA (0.25% Trypsin, 1 mM
EDTA) and subcultured at a split ratio of 1:10. D,L-sulforaphane
(SFN; Sigma-Aldrich, St. Louis, MO-USA) was dissolved in
DMSO (Sigma-Aldrich, St. Louis, MO-USA) at a 10 mM stock
concentration and stored at 220uC. Cells were allowed to adhere
for 24 h and medium was replaced with fresh medium containing
0, 5, 10, and 20 mM SFN. Cells were exposed for 24 and 48 h.
Cell Morphology and Confluence
Throughout the experiment, cultures were routinely visualised
for confluence and cell morphology. Control and SFN-exposed
MG-63 cells were daily observed under inverted microscopy in a
Nikon Eclipse TS100 microscope (Nikon, Tokyo, Japan) for
confluence and changes in morphology between control and
exposed cells.
Cell Viability and Apoptosis
Cell viability and apoptosis were analysed by flow cytometry
(FCM) in a Coulter Epics XL Flow Cytometer (Beckman Coulter,
Hialeah, FL-USA), using the FITC Annexin V Apoptosis
Detection Kit I (BD Pharmingen, San Diego, CA-USA) as
recommended by the manufacturer. Briefly, cells were harvested
and washed with PBS, pH 7.2. Cells were resuspended in diluted
binding buffer provided with the kit (1:10 in distilled water) at
16106 cells/ml. Five microliters FITC-Annexin V and 5 ml
propidium iodide (PI; Sigma-Aldrich; St. Luis, MO-USA) were
used to stain 100 ml cell suspension for 15 min at room
temperature in the dark, after which each sample was diluted in
400 ml binding buffer. At least 10,000 events were analysed for
each sample and percentages were calculated from the number of
cells in each quadrant divided by the total number of cells.
Determination of Caspase-3 Activity
Caspase-3 activity was determined using the APOPCYTO
Caspase-3 Colorimetric Assay Kit (MBL, Nagoya, Japan), with few
modifications. In brief, control cells or cells exposed to 10 or
20 mM SFN for 48 h were washed with PBS and collected after
trypsinization. Cells (1.56106) were collected by centrifugation,
resuspended in 100 ml cell lysis buffer provided with the kit and
incubated on ice for 10 min. After centrifugation at 10,000 g, 4uC
for 5 min, the cleared cell extract was collected and placed on ice
and total protein concentration was determined (see below, under
Protein quantification subsection) The final reaction contained 1
vol. 26 reaction buffer containing 10 mM DTT : 1 vol. cell
extract : 0.1 vol. 10 mM Caspase-3 substrate DEVD-p-nitroani-
lide. Inhibition control reactions containing 10 mM DEVD-FMK
inhibitor were also performed. Microplates were incubated at
37uC, in the dark for 18 h, and A405 nm was subsequently
measured in 96-well plates in a Synergy HT Multi-mode
Microplate Reader (BioTek Instruments, Winooski, VT-USA).
Caspase-3 activity was extrapolated from a p-nitroanilide substrate
standard curve, and caspase-3 specific activity was calculated
according to the manufacturer’s protocol.
Total Antioxidant Activity (TAA)
For the TAA assay, the Antioxidant Assay Kit (Sigma-Aldrich,
St. Louis, MO-USA) was used. Cell homogenates were prepared
as described by Quick and co-workers [31] with modifications.
Briefly, cells were scraped in cold PBS and centrifuged at 1,000 g,
for 10 min, at 4uC. The cell pellet was resuspended in assay buffer
and sonicated for 30 s. The homogenates were centrifuged at
12,000 g for 15 min at 4uC, and the supernatants were stored at 2
80uC until further analysis. Reaction with 2,29-azino-bis(3-
ethylbenzthiazoline-6-sulfonic acid) (ABTS) and spectrophotomet-
ric measurements were according to the kit manufacturer’s
instructions.
Determination of Intracellular Reduced Glutathione
(GSH) Levels
For GSH quantification, the Glutathione Assay Kit, Fluorimet-
ric (Sigma-Aldrich, St. Louis, MO-USA) was used. In brief, 105
cells/ml were seeded in a fluorimetric 96-well plate. After
exposure, cells were washed with PBS, the kit reagents were
added and fluorescence was measured on microplate reader at
360-nm excitation and 485-nm emission. In parallel with sample
measurement, a calibration curve was performed with GSH
standard to extrapolate sample concentration. In order to
normalise GSH levels, total protein content was determined for
each sample. After fluorimetric reading, cells were washed with
PBS, incubated with the Glutathione Assay Kit’s lysis buffer
during 30 min in shaker. After this, 5 ml of homogenate were
taken to a new well and total protein content was determined for
each sample (see below, under Protein quantification subsection).
Intracellular ROS Formation
Intracellular ROS production was assessed by FCM with the
use of dichlorodihydrofluorescein diacetate (Sigma-Aldrich, St.
Louis, MO-USA) fluorescent probe. After SFN exposure, medium
was discarded and cells were incubated for 30 min, at 37uC, in the
dark with serum-free a-MEM containing 10 mM dichlorodihydro-
fluorescein diacetate. Cells were washed with PBS, trypsinised, and
collected for analysis. ROS formation was estimated from the
median fluorescence intensity (MFI) of dichlorofluorescein using
the FlowJo software (Tree Star Inc., Ashland, OR-USA).
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Enzyme Activity Assays
Adherent subconfluent cells were washed with PBS and scraped.
Cells were collected by centrifugation, resuspended in a variable
volume of cold 5 mM phosphate buffer (5 mM potassium
phosphate, 1 mM EDTA, pH 7.4) and sonicated for 30 s. After
centrifugation at 12,000 g, 4uC for 15 min, cleared cell extracts
were collected.
For Cat, superoxide dismutase (SOD) and glutathione reductase
(GR) enzyme assays, , 56106 cells were resuspended in 750 ml
cold 5 mM phosphate buffer and assayed at 25uC. From the
cleared cell extracts, Cat activity was determined by monitoring
oxygen formation from H2O2 decay. For this, 25 ml of each
cleared cell extract were added to 925 ml phosphate buffer
(50 mM potassium phosphate, 5 mM EDTA, pH 7.4). Back-
ground O2 formation was determined in an Oxygraph System
instrument (Hansatech Instruments, Norfolk, UK), and subse-
quently 50 ml H2O2 were added. Cat activity was determined from
H2O2 conversion to O2, normalised to background O2 formation.
Total SOD activity was determined using the SOD-assay kit
(Sigma-Aldrich, St. Louis, MO-USA) and A440 nm was followed.
GR activity assay was carried out according to Dringen and
Gutterer [32] with some modifications. The reaction was carried
in 100 mM phosphate buffer (100 mM potassium phosphate,
1 mM EDTA, pH 7.4) and additionally contained 0.2 mM
NADPH (Sigma-Aldrich, St. Louis, MO-USA) and 1 mM
glutathione disulfide (GSSG; Sigma-Aldrich, St. Louis, MO-
USA), in a final 320-ml volume. A GR calibration curve was used
to determine GR activity in samples.
For the GPx enzyme assay, ,56106 cells were resuspended in
350 ml cold 5 mM phosphate buffer and sonicated for 30 s once
on ice. From the cleared cell extracts, GPx activity was determined
as described by Smith and Levander [33] with some alterations.
Briefly, cleared cell extract (50 ml) prepared as described above
was diluted in phosphate buffer to the final concentrations 50 mM
potassium phosphate, 5 mM of EDTA, pH 7.4, containing 2 mM
GSH, 1 mM sodium azide (Sigma-Aldrich, St. Louis, MO-USA),
0.4 mM NADPH and 2 U/ml GR (Sigma-Aldrich, St. Louis,
MO-USA). The reaction was initiated by the addition of 10 ml tert-
butyl hydroperoxide solution (Sigma-Aldrich, St. Louis, MO-
USA), incubated at room temperature and A340 nm was
measured. SOD, GR and GPx enzyme assays were carried out
in 96-well plates in a microplate reader.
Protein Quantification
Total protein quantification was done using Bradford Reagent
(Sigma-Aldrich, St. Louis, MO-USA) and following the manufac-
turer’s instructions. Five microliters of sample were taken to a 96-
well plate and 250 ml of Bradford Reagent were added. The plate
remained in agitation in darkness for 10 min and protein content
was determined after this period.
Assessment of mRNA Expression
Gene-specific primers (Table 1) were designed using the
Primer3 design tool [34] and were tested for unique hits in the
human genome by the UCSC In-Silico PCR tool (http://genome.
ucsc.edu/cgi-bin/hgPcr?command = start). RNA was extracted
from MG-63 control cells and cells exposed to 10 mM SFN for
48 h, using the TRIzol method. Organic phase separation was
achieved in Phase Lock Gel Heavy tubes (5 PRIME Inc., Boulder,
CO-USA). The aqueous phase was mixed with 1 vol. 70% ethanol
and RNA was purified using RNeasy Mini Kit columns (Qiagen,
Hilden, Germany). For cDNA synthesis, 2 mg total RNA were pre-
incubated with DNase I (Sigma-Aldrich, St. Louis, MO-USA),
DNase I was inactivated and total RNA was reverse-transcribed
with 1 mM Oligo (dT)18, using the Omniscript RT Kit (Qiagen,
Hilden, Germany). The cDNA samples were prediluted in
ultrapure MilliQ water (1:20). The final individual qPCR reactions
contained iQ SYBR Green Supermix (BioRad, Hercules, CA-
USA), 1.5 mM each gene-specific primer and 1:4 (v/v) prediluted
cDNA (1:20). The qPCR program included 1 min denaturation at
95uC, followed by 40 cycles at 94uC for 5 s, 58uC for 15 s, and
72uC for 15 s. After qPCR, a melting temperature program was
performed. At least three qPCR technical replicates were
performed per sample from each of two independent biological
assays. Average PCR efficiencies and cycle thresholds were
estimated from the fluorescence data using the algorithm Real-
Time PCR Miner [35]. The estimated average efficiencies and
cycle thresholds were used to determine gene expression of
exposed cells relative to control cells and normalised with the
GAPDH reference gene, following the Pfaffl method [36].
Correlation Analysis
Pearson correlation analysis was performed to investigate the
association between different parameters related to oxidative stress
and apoptosis in cells exposed to 0, 5, 10, and 20 mM SFN for 24
and 48 h. Correlations were considered significant for p,0.05.
Statistical Analysis
For most quantitative assays, three independent assays with at
least three technical replicates were performed. For qPCR analysis
and caspase-3 activity assay, two independent assays with at least
three replicates were performed. For determination of intracellular
GSH levels, two independent assays with two replicates each were
considered. The statistical analysis was performed using SigmaPlot
for Windows version 11.0 (Systat Software Inc., San Jose, CA-
USA). Statistical significance between control and SFN-treated
groups was evaluated by one-way or two-way ANOVA followed
by Holm-Sidak’s test. When necessary, data were transformed to
achieve normality and equality of variances. The differences were
considered significant for p,0.05. The data were expressed as
mean6 SEM. Pearson’s correlations for the tested endpoints were
considered significant for p,0.05 and p,0.01.
Results
SFN Induces Morphological Changes, Apoptosis and
Viability Loss in MG-63 Cells
Relative to control, cells treated with SFN showed morpholog-
ical alterations, such as cell enlargement and loss of adherence,
which were more noticeable for exposure to 10 and 20 mM SFN,
as visualised by inverted microscopy (Fig. 1). Moreover, the
presence of SFN resulted in a concentration-dependent decrease in
the number of cells with exposure time.
In addition to the observed altered morphology and lower cell
number, SFN decreased the%viable cells in a concentration-
dependent manner, as determined by incubation with FITC-
Annexin V conjugate and PI (Fig. 2A, B). Noteworthy, a sharp
decline was observed in cell viability from 5 to 10 mM SFN
exposure, particularly for the 48-h exposure period. For the 10 and
20 mM concentrations, SFN exposure increased the%cells in early
or late apoptosis/necrosis. For these concentrations, cells addi-
tionally showed an increase in caspase-3 activity (Fig. 2C).
SFN Induces a General Antioxidant Response but
Decreases Intracellular GSH Levels in MG-63 Cells
The intracellular redox balance is mostly determined by the
action of specific oxidoreductases and antioxidants, e.g. the
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reduced non-protein thiol GSH. In this study, exposure to 20 mM
SFN resulted in a significant decrease in the intracellular
antioxidant activity (Fig. 3A) and was associated with decreased
intracellular GSH levels for the 24-h exposure period (Fig. 3B).
Although the antioxidant activity increased from 24 to 48 h
exposure, intracellular GSH decreased within the same period.
This effect was independent of SFN exposure, as also the control
cells exhibited this trend, suggesting that intracellular GSH levels
decreased over time and other antioxidants e. g. thioredoxin took
over the role of GSH.
The antioxidant response was also analysed at the transcrip-
tional level. SFN is a well-known inducer of phase 2 enzymes via
the Nrf2 transcriptional activator. In this study, the TXNRD1 gene,
encoding thioredoxin reductase 1 which functions in the general
antioxidant response, was induced by SFN treatment (Fig. 3C).
Moreover, a slight increase was observed in the expression of
NQO1, encoding NAD(P)H:quinone oxidoreductase 1, a flavopro-
tein that catalyses a 2-electron reduction of quinone in the electron
respiratory chain and functions as a superoxide scavenger. In
contrast to this, the expression of genes encoding the two
ubiquitous glutathione-S-transferases M1 and M4 was not
increased by SFN treatment and GSTM4 expression was found
decreased after SFN treatment. Collectively, these results indicated
that although SFN induce an antioxidant response, the increasing
Table 1. Oligonucleotide primers used for qPCR.
Target gene Forward primer (59-39) Reverse primer (59-39)
CAT TGAACTGTCCCTACCGTGCT TATTGGATGCTGTGCTCCAG
GAPDH ACACCCACTCCTCCACCTTT TACTCCTTGGAGGCCATGTG
GPX1 CGGGACTACACCCAGATGAA TCTCTTCGTTCTTGGCGTTC
GSTM1 CAGAGCAACGCCATCTTGT GCCAGCTGCATATGGTTGT
GSTM4 AGAGCAACGCCATCCTGT GATTGGAGACGTCCATAGCC
GSR GATCCCAAGCCCACAATAGA TCGCTGGTTATTCCTAAGCTG
NQO1 GCACTGATCGTACTGGCTCAC GACTCCACCACCTCCCATC
SOD1 GGTGTGGCCGATGTGTCTAT TTCCAGCGTTTCCTGTCTTT
SOD2 CCCTGGAACCTCACATCAAC CTGAAGAGCTATCTGGGCTGTAA
TXNRD1 GTGGGCTTTCACGTACTGG CTGCACAGACAGGGTGGA
doi:10.1371/journal.pone.0092980.t001
Figure 1. Effect of SFN treatment on cell morphology. Cells were exposed for 24 h. (A) Control cells. (B–D) Cells exposed to 5, 10, or 20 mM SFN
respectively. Scale bar: 100 mm.
doi:10.1371/journal.pone.0092980.g001
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concentrations up to 20 mM SFN resulted in gradually decreased
antioxidant defenses in MG-63 cells, associated with depletion of
intracellular GSH.
SFN Treatment Increases Intracellular ROS Formation and
Inhibits ROS-scavenging Enzymes
SFN treatment induced ROS accumulation in a concentration-
dependent manner (Fig. 4), an observation that was confirmed by
correlation analysis (p,0.01; Table 2). The increase in intracel-
lular ROS was not gradual between the 5 and 10 mM SFN
exposure, and a sharp increase was observed particularly for the
48-h exposure period. Moreover, for 10 mM SFN, longer exposure
times resulted in larger accumulation of intracellular ROS.
The apoptosis-related parameters investigated, viz. caspase-3
activity and%early and late apoptosis, were found positively
correlated with ROS levels (p,0.05; Table 2).
SFN induced a decrease in the activity of ROS-scavenging
enzymes and enzymes involved in GSH regeneration (Fig. 5A–D).
Increased ROS formation was associated with decreased SOD,
GPx and GR enzyme activities, as given by correlation analysis
(p,0.05; Table 2).
For the ROS-scavenging enzymes SOD, Cat and GPx, enzyme
activity was significantly inhibited by higher SFN concentrations
(Fig. 5A–C). SOD activity was affected by time only at higher SFN
concentrations of 10 mM and above. Cat activity was affected by
time independently of SFN treatment, since in control cells Cat
activity decreased by 40% from 24 h to 48 h. Nevertheless, in cells
exposed to 20 mM SFN, Cat activity decreased by 80% for the
same period, thereby suggesting an additional effect caused by
SFN treatment. In cells exposed to 10 mM SFN for 48 h, SOD1
and SOD2 gene expression was increased, whereas CAT expression
was decreased (Fig. 5E). To some extent, this observation may
explain the more pronounced effects of SFN in decreasing Cat
activity compared to SOD activity. Upon SFN treatment, GPx
gene expression and enzyme activity were both found significantly
decreased and showed strong correlation with ROS accumulation
in cells (p,0.01; Table 2). Moreover, apart from decreased GPx
activity, SFN treatment resulted in decreased GR activity,
suggesting that GSH regeneration was overall less effective in
cells exposed to 10 mM or higher SFN concentrations. Moreover,
for the lowest SFN concentration, i.e.5 mM, the decrease in
enzyme activity was larger for GPx compared to GR, and this
potentially stimulated the increase in intracellular GSH levels that
was not found at higher SFN concentrations.
Discussion
Compared to what is documented for other tumours, SFN
cytotoxicity against osteosarcoma cells is still poorly studied and its
effects on the oxidative state of osteosarcoma have remained
uncharacterised. At 10 mM concentration or higher, SFN
decreased cell viability, increased the%early apoptotic cells and
increased caspase 3 activity. In previous work using identical
conditions, a decrease in viability was already found at 5 mM SFN,
as assessed by the 3-(4,5-dimethyl-2-thiazolyl)-2,5-diphenyl tetra-
zolium bromide (MTT) assay which assays mitochondrial activity
[37].
Figure 2. Cytotoxicity and apoptosis induction by SFN. (A, B) Cells were incubated with FITC-Annexin V conjugate and PI after SFN exposure
for 24 or 48 h respectively. Data shown are mean6 SEM (n = 3). *, significantly different between control and SFN-treated cells (p,0.05). (C) Caspase-
3 activity. Cells were exposed for 48 h, the cleared cell extracts were incubated with DEVD-p-nitroanilide and caspase-3 activity was measured
spectrophotometrically. Data shown are mean 6 SEM (n= 2).
doi:10.1371/journal.pone.0092980.g002
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In a study by Matsui and colleagues, SFN was shown to act as a
sensitiser to TRAIL-induced apoptosis through DR5 receptor
increased expression, in two p53 null osteosarcoma cell lines,
including MG-63 [17]. Moreover, in hepatoma cells, Kim and co-
workers showed that Cat overexpression almost completely
blocked TRAIL-induced apoptosis both in p53 wild-type and
mutant cells [22]. These observations served as basis for this study,
in which independent apoptotic markers such as the presence of
cell surface phosphatidylserine or caspase-3 activation revealed
positive correlation with ROS accumulation in MG-63 cells. In
this study, the%early and late apoptotic cells was found
significantly increased with SFN doses, compared to control.
Between 5 and 10 uM SFN,%of early apoptotic cells increased 2.5
fold for 24-h exposure and 2.8 fold for 48-h exposure. The
increase in%apoptotic cells was nevertheless not linear with SFN
dose for all SFN concentrations tested. Rather, a plateau seems to
occur at higher doses, although SFN doses above 20 mM were not
tested to confirm this. A concentration-dependent effect of SFN
cannot be ruled out and further conclusions based on threshold
assumptions in SFN studies must be regarded carefully. Tumour
cells typically generate higher ROS levels compared to normal
cells, e.g. [38], so this study investigated the association between
ROS production and different endpoints in the presence of SFN.
Pearson correlation test supports (Table 2) the hypothesis that the
increase of apoptosis is correlated with the increase in ROS levels,
which was steeper between 5 and 10 mM (Fig. 4).
Several studies have shown that lower SFN concentrations
typically up to 5 mM SFN increase the intracellular GSH pool in
many cell lines [39], [40], [41], [42]. However, additional reports
Figure 3. Antioxidant state after SFN treatment. (A) Total antioxidant activity (TAA). TAA was determined spectrophotometrically from cell
extracts incubated with ABTS reagent. Data shown are mean 6 SEM (n= 3). *, significantly different between control and SFN-treated cells (p,0.05).
a,b, significantly different between times (p,0.05). (B) Intracellular GSH levels for the SFN concentrations and exposure times indicated. Data shown
are mean 6 SEM (n = 2). *, significantly different between the indicated groups (p,0.05). a,b, significantly different between times (p,0.05). (C)
Relative gene expression of selected phase 2 enzymes exposed to 10 uM SFN for 48 h. Data shown are mean 6 SEM (n= 2). *, significantly different
between control and SFN-treated cells (p,0.05).
doi:10.1371/journal.pone.0092980.g003
Figure 4. ROS accumulation after SFN treatment. Cells were
incubated with10 mM dichlorodihydrofluorescein diacetate and ROS
accumulation was estimated from MFI by FCM. Data shown are mean6
SEM (n= 3). *, significantly different between control and SFN-treated
cells (p,0.05). a,b, significantly different between times (p,0.05).
doi:10.1371/journal.pone.0092980.g004
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have revealed that depending on cell line, higher SFN concentra-
tions rapidly and markedly deplete the intracellular GSH levels
[23], [43]. In this work, a dual response was observed for the
intracellular GSH levels, characterised by an increase in GSH
levels at 5 mM SFN exposure, followed by a significant decrease
for the higher concentration tested. Hu and coleagues showed that
SFN inhibits GR in A549 cell line and in cell-free systems, cell and
proposed direct covalent binding to cysteine catalytic residues as
the main inhibition mechanism [44]. Our results agree with the
observations of Hu and colleagues for GR inhibition, however, in
the study from Hu and colleagues SFN did not significantly
decrease GPx expression or enzyme activity in A549 cells, unlike
what was found in our study with MG-63 cells. The decreased
GPx expression and activity in MG-63 cells exposed to SFN
compared to A549 from the study of Hu and colleagues could
point to different sensitivities of cell lines to oxidative stress
regulation. The main enzymes responsible for peroxide detoxifi-
cation are Cat and GPx. Under the conditions tested, these
enzymes showed significantly lower activity at 10 uM SFN for
48 h, with GPx already decreased at 5 uM SFN for 48 h. These
results are also reflected at the gene expression, with Cat
expression decreased, and GPx1 expression significantly de-
creased. SOD activity was not so significantly affected by SFN
in percentage and one possible reason for this is suggested by the
Figure 5. Effect of SFN on the activity and gene expression of selected oxidoreductases involved in ROS detoxification and GSH
regeneration. (A–D) SOD, Cat, GPx and GR specific activities, respectively. Data shown are mean in U/mg total protein 6 SEM (n= 3). *, significantly
different between control and SFN-treated cells (p,0.05). a,b, significantly different between times (p,0.05). (E) Relative gene expression for cells
exposed to 10 mM SFN for 48 h. Data shown are mean 6 SEM (n = 2). *, significantly different between control and SFN-treated cells (p,0.05).
doi:10.1371/journal.pone.0092980.g005
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gene expression results, since SOD genes were found more
expressed in the experimental condition. Gene expression
quantification for all conditions and both exposure times might
provide more insight into the variation of corresponding gene
expression.
Apart from direct reaction of SFN with GSH, the decreased
GPx and GR activities, and consequent poor GSH regeneration,
might also explain the lower GSH levels found at higher SFN
concentrations.
From the%viable cells, ROS levels and SOD, Cat, GPx enzyme
activities, it may be concluded that exposure to 10 mM SFN for
48 h produced significant pro-oxidant effects. Several genes are
transcriptionally activated by Nrf2. In order to better understand
the general antioxidant defences of MG-63 cells, the Nrf2-ARE
response was analysed. TXNRD1 and NQO1, known to be
positively regulated by Nrf2, were found expressed at higher levels
upon exposure to SFN and TXNRD1 was significantly overex-
pressed; however, the two glutathione transferase genes studied
which are also under the regulation of Nrf2 were not overex-
pressed. These results suggest that activation by Nrf2 was not
complete under the given experimental conditions, and that the
antioxidant response was limited.
Besides eliciting a dual response in GSH levels, exposure to
increasing SFN concentrations resulted in a non-linear steep
increase in intracellular ROS levels between non-exposed control
and cells exposed to10 mM SFN. SFN is known to induce changes
in the intracellular redox balance and depending on its concen-
tration, exposure time or the exposed cell line, it may promote
antioxidant or pro-oxidant response. In vitro, a predominantly
antioxidant response has been reported at low SFN concentra-
tions, e.g. up to 5 mM SFN for up to 24 h, or alternatively higher
SFN concentrations for only few hours exposure [40], [42], [45],
[46], [47]. On the other hand, and notwithstanding a possible
antioxidant response, enhanced ROS accumulation has been
previously documented in cells exposed to higher SFN concen-
trations, e.g. above 5 mM, or to long-lasting exposure periods,
typically above the 24 h [26], [27], [42], [47], [48]. Moreover, it
has been previously observed that SFN even at lower doses can be
cytotoxic to multiple myeloma, suggesting that a subgroup of
cancer cells may be extremely susceptible to SFN cytotoxic effects
[49]. In the present study, the cytotoxic and pro-oxidant effects of
SFN were found to be dependent on concentration and exposure
period, although not following a linear correlation, and this
deserves further investigation in in vivo experiments evaluating the
role of SFN as coadjuvant in chemotherapy, prior to human trials.
In the case of osteosarcoma, this study reveals different
alterations leading to increased oxidative stress induced by SFN
(summarised in Fig. 6).
As hypothesised in scheme for p53 null cells (Fig. 6), the ROS
levels induced by SFN may contribute to effects such as G2/M
phase arrest, loss of mitochondrial membrane potential (MMP)
and p53-independent apoptosis. It is well known that cancer cells
have higher glycolytic fluxes compared to normal cells and
mitochondrial dysfunction in cancer is often related to this
preferential use for glycolysis. In this respect, mitochondrial
dysfunction and defective oxidative phosphorylation often associ-
ate with cancer cell survival and proliferation. Although the
interplay between p53 action and ROS generation is complex and
yet to decipher in p53 dysfunctional cells [e.g. 50], it would be
expected that p53-null tumour cells have decreased mitochondrial
respiration and generate less ROS. However, it has been
demonstrated that very often cancer cells (independently of the
p53 status) produce higher basal levels ROS, compared to normal
cells. Since cancer cells are subjected to high oxidative stress, they
may be more adapted and cope with small increments in ROS
levels. Nevertheless, a small increment in ROS levels may render
cancer cells more prone to deleterious events than the same ROS
increase in normal cells, as shown e.g. by the selective killing of
cancer cells promoted by the ROS-inducing piperlongumine [51]
but this hypothesis requires further confirmation for the action of
SFN on MG-63 oxidative stress and cell death compared to
normal cells.
Figure 6. Hypothetical roles of SFN in ROS initiation and cytotoxicity in MG-63 cells. ROS accumulation and cell death after SFN treatment.
ROS may accumulate as a consequence of combined decrease in GPx and Cat activities, together with overall decreased efficiency in glutathione
recycling and GSH regeneration. ROS accumulation may additionally decrease the mitochondrial membrane potential, leading to apoptosis. MMP:
mitochondrial membrane potential.
doi:10.1371/journal.pone.0092980.g006
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As shown in the hypothetical model (Fig. 6), SFN-related
deleterious effects may include e.g. DNA strand breaks, membrane
damage, and apoptosis induction [37]. Noteworthy, doxorubicin,
an anticancer drug commonly used in osteosarcoma therapy, has
been previously shown to induce intracellular ROS formation,
which was found necessary for mitochondrial membrane depo-
larization, pro-caspase 3 activation, apoptosis and G2/M phase
arrest in the p53-null SaOS-2 osteosarcoma cell line [52].
However, unlike doxorubicin which is cardiotoxic, SFN is still
not reported to present cardiotoxicity at the doses presented in this
study [53], [54].
In conclusion, from the toolbox of biomarkers tested, GPx
expression and activity were found the most sensitive endpoints for
prediction of oxidative stress in the studied model system. Despite
the complex regulation and multiple interactions of SFN with
different biomolecules, the reported anticancer mechanism is of
potential interest to osteosarcoma therapy and deserves further
investigation for this and other p53-null cancer cells that are
chemoresistant.
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